L39-20317-81268
3 vaccinations
2 coded responses
39 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 207 / MD
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Moderna
-
2021-02-09
Registered in v-safe
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-22
- 2021-03-01
-
2021-03-08
Dose 2 — Moderna
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-08
- 2021-04-12
- 2021-04-19
- 2021-06-07
- 2021-09-08
-
2021-12-06
Dose 3 — Moderna
- 2021-12-06
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-20
-
2021-12-27
Survey response — day 21, dose 3MedDRA: Chills, Headache, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Congestion, fever, chills, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-01-03
- 2022-01-10
- 2022-01-17
- 2022-06-06
-
2022-12-06
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Multiple serious colds associated with negative COVID home testsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Moderna | |
| 2 | 2021-03-08 | Moderna | |
| 3 | 2021-12-06 | Moderna | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Congestion, fever, chills, headache
Release 12 — 12 months, dose 3
Symptoms: Multiple serious colds associated with negative COVID home tests
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release